dasatinib teva 100 mg filmtabletta
teva b.v. - dasatinib -
calquence
astrazeneca ab - acalabrutinib - leukémia, limfocitikus, krónikus, b-sejt - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.
dasatinib alvogen 20 mg filmtabletta
alvogen pharma trading europe eood - dasatinib -
dasatinib alvogen 50 mg filmtabletta
alvogen pharma trading europe eood - dasatinib -
dasatinib alvogen 70 mg filmtabletta
alvogen pharma trading europe eood - dasatinib -
dasatinib alvogen 80 mg filmtabletta
alvogen pharma trading europe eood - dasatinib -
dasatinib alvogen 100 mg filmtabletta
alvogen pharma trading europe eood - dasatinib -
dasatinib alvogen 140 mg filmtabletta
alvogen pharma trading europe eood - dasatinib -
dasatinib krka 20 mg filmtabletta
krka d.d., - dasatinib -
dasatinib krka 50 mg filmtabletta
krka d.d., - dasatinib -